Value of Ultra-fast Prostate MRI in Prostate Cancer
NCT05903781 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 536
Last updated 2025-05-14
Summary
This study aims to assess the value of ultra-fast MRI sequences in the assessment of prostate cancer, compared to the full multiparametric/biparametric protocol as the clinical standard.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Prostate MRI
MRI of the prostate
Sponsors & Collaborators
-
University of Zurich
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-26
- Primary Completion
- 2025-02-18
- Completion
- 2025-02-18
Countries
- Switzerland
Study Locations
More Related Trials
-
MRI-targeted Biopsy of the Prostate: Software Versus Visual Registration in the Accuracy of Prostate Cancer Detection
NCT03819751 ·Status: RECRUITING ·Phase: NA
-
18F-PSMA-1007 PET Imaging to Detect Primary Prostate Cancer
NCT04487847 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Magnetic Resonance Imaging to Locate and Characterize Prostate Cancer
NCT00082147 ·Status: COMPLETED ·Phase: NA
-
Assessment of Prostate MRI Before Prostate Biopsies
NCT02485379 ·Status: COMPLETED ·Phase: NA
-
The Value of Dual-parametric Magnetic Resonance Combined With Regional Saturation Biopsy in Patients With Suspected Prostate Cancer
NCT06824259 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Combining High-frequency Micro-ultrasound and Multiparametric MRI Target Biopsy for Detecting Prostate Cancer
NCT06579911 ·Status: RECRUITING ·Phase: NA
-
Detection of Clinically Significant Prostate Cancer Using Transperineal Targeted Biopsy Compared to Standard Transrectal Biopsy
NCT03044197 ·Status: COMPLETED ·Phase: NA
-
Detection of Clinically Significant Prostate Cancer With 18F-DCFPyL PET/MR
NCT03149861 ·Status: COMPLETED ·Phase: NA
-
Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) Guided Biopsy in Men With Elevated PSA
NCT03187990 ·Status: COMPLETED ·Phase: NA
-
Biparametric MRI for Detection of Significant Prostate Cancer
NCT02584179 ·Status: COMPLETED ·Phase: NA
-
Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort
NCT05384535 ·Status: RECRUITING ·Phase: NA
-
Diagnostic Accuracy and Performance of 18F-PSMA-1007
NCT04986280 ·Status: COMPLETED
-
Novel MRI Assessment of Prostate Cancer VALIDATE-PRO
NCT05017181 ·Status: UNKNOWN
-
Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland Treatment
NCT07011342 ·Status: RECRUITING ·Phase: NA
-
Upright MRI for Prostate Cancer Screening
NCT03474913 ·Status: RECRUITING
-
Diagnostic Value of MRI-targeted Plus Index-lesion-ipsilaterally Systematic Biopsy for Biopsy-naive Men At Risk of Prostate Cancer
NCT06584279 ·Status: RECRUITING
-
MRI Before Biopsy in Diagnosing Patients With Prostate Cancer
NCT02131207 ·Status: TERMINATED
-
A Study of MRI-guided High-dose Radiation Therapy in Prostate Cancer
NCT04997018 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
MRI Screening in Men at High Risk of Developing Prostate Cancer
NCT05608694 ·Status: RECRUITING ·Phase: NA
-
Magnetic Resonance Imaging and Spectroscopy of the Prostate
NCT00590993 ·Status: COMPLETED
-
Correlation of Imaging Findings With Clinical Findings and Patient Outcomes in Prostate Cancer
NCT03122470 ·Status: WITHDRAWN ·Phase: NA
-
Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning
NCT02470910 ·Status: COMPLETED ·Phase: NA
-
Magnetic Resonance Imaging in Detecting Cancer Progression in Patients With Early Stage Prostate Cancer Undergoing Active Surveillance
NCT00796874 ·Status: WITHDRAWN ·Phase: NA
-
MR Radiomic Features in Prostate Cancer
NCT04219059 ·Status: COMPLETED
-
Targeted And Perilesional Or Systematic Biopsy In Prostate Cancer
NCT07296042 ·Status: NOT_YET_RECRUITING ·Phase: NA